You are viewing the site in preview mode

Skip to main content

Table 1 Comparison of clinicopathologic characteristics according to the Gli1 expression in GA

From: Gli1 regulates stemness characteristics in gastric adenocarcinoma

VariableNGli1(−)n (%)Gli1(+)n (%)χ2RP
Age (years)   1.4480.0930.229
 < 6510932(29.4)77(70.6)   
 ≥ 656013(21.7)47(78.3)   
Sex   1.3470.0890.246
 Male10625(23.6)81(76.4)   
 Female6320(31.7)43(68.3)   
Tumor size (cm)   0.7590.0650.384
 < 4.56319(30.2)44(69.8)   
 ≥ 4.510626(24.5)80(75.5)   
Tumor grade   15.7710.0490.001*
 Well3114(45.2)17(54.8)   
 Moderate6611(16.7)55(83.3)   
 Poor7220(27.8)52(72.2)   
Tumor location   1.9430.0240.584
 Antrum9323(24.7)70(75.2)   
 Cardia30(0)3(100.0)   
 Body6320(31.7)43(68.3)   
 Mix102(20.0)8(80.0)   
pT stage   9.0340.2180.029*
 13516(45.7)19(54.3)   
 23811(28.9)27(71.1)   
 39217(18.5)75(81.5)   
 441(25.0)3(75.0)   
Lymph node metastasis   1.9490.1050.163
 Negative14441(28.5)103(71.5)   
 Positive254(16.0)21(84.0)   
Distant metastasis   7.4030.2080.007*
 Negative15145(29.8)106(70.2)   
 Positive180(0)18(100.0)   
Clinical stage   12.7990.2620.005*
 14418(40.9)26(59.1)   
 23411(32.4)23(67.6)   
 37316(21.9)57(78.1)   
 4180(0)18(100.0)   
Gross type   5.3650.1770.021*
 Early gastric cancer3716(43.2)21(56.8)   
 Advanced gastric cancer13229(22.0)103(78.0)   
Histological type   0.3890.0320.823
 Intestinal9126(28.6)65(71.4)   
 Diffuse7017(24.3)53(75.7)   
 Mix82(25.0)6(75.0)   
Survival   23.8830.375< 0.001*
 Die787(9.0)71(91.0)   
 Alive9138(41.8)53(58.2)   
  1. *Statistically significant findings